Large-scale testing (Phase 3)Not Yet RecruitingNCT07824986What this trial is testingTrial in Advanced Epithelioid MesotheliomaWho this might be right forPleural MesotheliomaMesothelioma Vivace Therapeutics, Inc 350
Testing effectiveness (Phase 2)Ended earlyNCT03233724What this trial is testingOral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasWho this might be right forCarcinoma, Non-Small-Cell LungLung CancerNon-Small Cell Lung Cancer+2 more National Cancer Institute (NCI) 9
Not applicableEnded earlyNCT00028782What this trial is testingEF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural CancerWho this might be right forAdvanced Malignant MesotheliomaLocalized Malignant MesotheliomaMalignant Ascites+2 more National Cancer Institute (NCI) 80
Not applicableStudy completedNCT01773655What this trial is testingClinical and Histopathologic Characteristics of BAP1 MutationsWho this might be right forMalignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more Memorial Sloan Kettering Cancer Center 196
Early research (Phase 1)Study completedNCT00398138What this trial is testingVaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaWho this might be right forLeukemiaLung CancerMalignant Mesothelioma+2 more Memorial Sloan Kettering Cancer Center 22
Early research (Phase 1)Ended earlyNCT04173338What this trial is testingCabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant MesotheliomaWho this might be right forNon Small Cell Lung CancerNon-squamous Non-small-cell Lung CancerUrothelial Carcinoma+1 more Augusta University 9
Testing effectiveness (Phase 2)Looking for participantsNCT04104776What this trial is testingTulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasWho this might be right forAdvanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5 more Novartis Pharmaceuticals 300
Testing effectiveness (Phase 2)Study completedNCT00025207What this trial is testingGefitinib in Treating Patients With Malignant MesotheliomaWho this might be right forAdvanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more National Cancer Institute (NCI) 40
Not applicableUnknownNCT04823741What this trial is testingMolecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural MesotheliomaWho this might be right forMesothelioma, MalignantGene AbnormalityPleural Mesothelioma Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282873What this trial is testingStudy of TYK-01054 Capsules in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor MalignanciesMalignant Mesothelioma (MM) TYK Medicines, Inc 219
Testing effectiveness (Phase 2)Active Not RecruitingNCT04287829What this trial is testingPembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma PatientsWho this might be right forMesotheliomas Pleural The Netherlands Cancer Institute 58
Testing effectiveness (Phase 2)Study completedNCT03048474What this trial is testingIpilimumab and Nivolumab in the Treatment of Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma The Netherlands Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT00002608What this trial is testingCombination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsWho this might be right forAdrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more Ottawa Regional Cancer Centre 30
Testing effectiveness (Phase 2)Study completedNCT02399371What this trial is testingPembrolizumab in Treating Patients With Malignant MesotheliomaWho this might be right forBiphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more University of Chicago 65
Early research (Phase 1)Study completedNCT00019825What this trial is testingDecitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraWho this might be right forEsophageal CancerLung CancerMalignant Mesothelioma+1 more National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06726564What this trial is testingMT027 in Patients with Pleural Malignant TumorsWho this might be right forAdvanced Malignant Solid TumorMalignant Pleural EffusionPleura Carcinoma+3 more Suzhou Maximum Bio-tech Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Early research (Phase 1)Study completedNCT03507452What this trial is testingFirst-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express MesothelinWho this might be right forAdvanced Recurrent Malignant Pleural Epithelioid MesotheliomaAdvanced Recurrent Malignant Peritoneal Epithelioid MesotheliomaAdvanced Recurrent Serous Ovarian Cancer+1 more Bayer 36
Early research (Phase 1)Study completedNCT01675765What this trial is testingSafety and Efficacy of Listeria in Combination With Chemotherapy as Front-line Treatment for Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Aduro Biotech, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115